Haploidentical haematopoietic stem cell transplantation using CD3 or CD3/CD19 depletion and conditioning with fludarabine, cyclophosphamide and antithymocyte globulin for acquired severe aplastic anaemia

Abstract

Fitzgibbon, J., Iqbal, S., Davies, A., O’Shea, D.,Carlotti, E., Chaplin, T., Matthews, J., Raghavan,M., Norton, A., Lister, T.A. & Young, B.D.(2007) Genome-wide detection of recurring sitesof uniparental disomy in follicular and trans-formed follicular lymphoma. Leukemia, 21,1514–1520.Mao, Z., Quintanilla-Martinez, L., Raffeld, M.,Richter, M., Krugmann, J., Burek, C., Hartmann,E., Rudiger, T., Jaffe, E.S., Muller-Hermelink,H.K., Ott, G., Fend, F. & Rosenwald, A. (2007)IgVH mutational status and clonality analysis ofRichter’s transformation: diffuse large B-celllymphoma and Hodgkin lymphoma in associa-tion with B-cell chronic lymphocytic leukemia(B-CLL) represent 2 different pathways of diseaseevolution. American Journal of Surgical Pathology,31, 1605–1614.Rossi, D. & Gaidano, G. (2009) Richter syndrome:molecular insights and clinical perspectives.Hematologcal Oncology ,27, 1–10.Scandurra, M., Rossi, D., Deambrogi, C., Rancoita,P.M., Chigrinova, E., Mian, M., Cerri, M., Rasi,S., Sozzi, E., Forconi, F., Ponzoni, M., Moreno,S.M., Piris, M.A., Inghirami, G., Zucca, E., Gattei,V., Rinaldi, A., Kwee, I., Gaidano, G. & Bertoni,F. (2010) Genomic profiling of Richter’ssyndrome: recurrent lesions and differences withde novo diffuse large B-cell lymphomas. Hema-tologcal Oncology, 28, 62–67.Smit, L.A., van Maldegem, F., Langerak, A.W., vander Schoot, C.E., de Wit, M.J., Bea, S., Campo,E., Bende, R.J. & van Noesel, C.J. (2006) Anti-gen receptors and somatic hypermutation inB-cell chronic lymphocytic leukemia with Rich-ter’s transformation. Haematologica 91, 903–911.Timar, B., Fulop, Z., Csernus, B., Angster, C., Bog-nar, A., Szepesi, A., Kopper, L. & Matolcsy, A.(2004) Relationship between the mutational sta-tus of VH genes and pathogenesis of diffuse largeB-cell lymphoma in Richter’s syndrome. Leuke-mia, 18, 326–330.